Arndt Vogel· @ArndtVogel · X·· 2 天前评分70
正文 · 原文
W&W strategy for dostarlimab in localized deficient dMMR/MSI-H GC/GEJC: Results from the first interim analysis of the GERCOR-GONO DEWI phase II study
#ESMO26 #ESMOAmbassadors
👉 25pts enrolled, 33% of pts achieved cCR at 1yr
👉 1 pts with PD
🧐Study continues
@myESMO @ASCO
424 浏览 · 6 赞 · 7 转发 · 0 回复
会议摘要
2877RO按 Rapid oral 1: Gastrointestinal tumour, upper digestive 对上
Watch-and-wait (W&W) strategy for dostarlimab in localized deficient dMMR/MSI-H gastroesophageal adenocarcinoma (GEA): Results from the first interim analysis of the GERCOR-GONO DEWI phase II study
https://esmocongress.esmo.org来源：Arndt Vogel · x.com